Cardiac Toxicity Terminated Phase 2 Trials for Doxorubicin (DB00997)

IndicationStatusPhase
DBCOND0028520 (Cardiac Toxicity)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00019864Combination Chemotherapy Before and After Surgery in Treating Patients With OsteosarcomaTreatment